Member Exclusive NEWS ROUND-UP

Cell therapy weekly: FDA warns manufacturer of unapproved cord blood therapies

This week: First Australian T-cell therapy manufacturing license awarded and a biotech acquisition aims to progress the marketing of potentially curative type 1 diabetes cell therapies.

Go to the profile of RegMedNet
Sep 05, 2019

Please sign in or register for FREE

No comments yet.